DISC MEDICINE INC's ticker is and the CUSIP is 254604101. A total of 113 filers reported holding DISC MEDICINE INC in Q4 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $808 | -9.9% | 17,943 | +24.4% | 0.00% | – |
| Q1 2024 | $897 | -45.4% | 14,423 | -49.3% | 0.00% | -100.0% |
| Q4 2023 | $1,643 | +10.8% | 28,464 | -9.8% | 0.00% | 0.0% |
| Q3 2023 | $1,483 | +2049.3% | 31,561 | +1932.3% | 0.00% | – |
| Q2 2023 | $69 | -42.0% | 1,553 | -72.4% | 0.00% | – |
| Q1 2023 | $119 | +2875.0% | 5,619 | +2709.5% | 0.00% | – |
| Q4 2022 | $4 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 2,509,456 | $113,101,182 | 11.91% |
| Bain Capital Life Sciences Investors, LLC | 1,795,735 | $80,933,776 | 8.89% |
| Foresite Capital Management V, LLC | 299,069 | $13,479,040 | 8.61% |
| Saturn V Capital Management LP | 503,089 | $22,674,221 | 8.57% |
| Paradigm Biocapital Advisors LP | 2,704,718 | $121,901,640 | 4.66% |
| Ally Bridge Group (NY) LLC | 166,500 | $7,504,155 | 4.47% |
| Frazier Life Sciences Management, L.P. | 1,754,834 | $79,090,368 | 3.70% |
| Logos Global Management LP | 925,000 | $41,689,750 | 3.38% |
| Blue Owl Capital Holdings LP | 215,260 | $9,701,768 | 2.70% |
| Exome Asset Management LLC | 61,000 | $2,749,270 | 2.39% |